Neuropsychopharmacology
- In memoriam: Dr. Thomas Lehner2 years ago
- The impact of ovulation-suppressing contraceptives on behavioral and functional difficulties in borderline personality disorder2 years ago
- Multivariate patterns among multimodal neuroimaging and clinical, cognitive, and daily functioning characteristics in bipolar disorder2 years ago
- Epac2 activation drives calcium permeable-AMPA receptor accumulation, fueling the incubation of cocaine craving2 years ago
- The relationship between electric field strength induced by electroconvulsive therapy and cognitive and antidepressant outcomes2 years ago
- Quantifying VMAT2 target occupancy at effective valbenazine doses and comparing to a novel VMAT2 inhibitor: a translational PET study2 years ago
- In remembrance of Herbert Pardes, M.D. July 7, 1934–April 30, 20242 years ago
Journal of Psychopharmacology
- We need to talk: The urgent conversation on chronic pain, mental health, prescribing patterns and the opioid crisis4 years ago
- Clozapine rechallenge or continuation despite neutropenia or agranulocytosis using colony-stimulating factor: A systematic review4 years ago
- Associations of antidepressants and antipsychotics with lipid parameters: Do CYP2C19/CYP2D6 genes play a role? A UK population-based study4 years ago
- A phase 1b study to investigate the potential interactions between ASP8062 and buprenorphine/naloxone in patients with opioid use disorder4 years ago
- Comparison of locomotor stimulant and drug discrimination effects of four synthetic cathinones to commonly abused psychostimulants4 years ago
- Co-medication with disulfiram markedly increased serum clozapine levels: Two case reports4 years ago
- The D1/D2-like receptor antagonist flupentixol and the D2-like receptor antagonist L-741626 decrease operant responding for nicotine and food and locomotor activity in male and female rats4 years ago
European Neuropsychopharmacology
- A shared decision journey to bridge the gap between treatment recommendation and low adherence?4 years ago
- Neuroimaging revealed long-lasting glucose metabolism changes to morphine withdrawal in rats pretreated with the cannabinoid agonist CP-55,940 during periadolescence4 years ago
- Treating major depressive disorder with mixed features4 years ago
- New biomarkers in mood disorders: Insights from immunopsychiatry and neuroimaging4 years ago
- In vivo serotonin transporter and 1A receptor binding potential and ecological momentary assessment (EMA) of stress in major depression and suicidal behavior4 years ago
- Vortioxetine improves physical and cognitive symptoms in patients with post-COVID-19 major depressive episodes4 years ago
- Initial response to the COVID-19 pandemic on real-life well-being, social contact and roaming behavior in patients with schizophrenia, major depression and healthy controls: A longitudinal ecological momentary assessment study4 years ago